Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):828-830.
doi: 10.1016/j.arbres.2020.08.007.
Epub 2020 Sep 24.
[Article in
English,
Spanish]
Affiliations
- 1 COVID-19 Management Team, Mymensingh Medical College and Hospital, Mymensingh, Bangladesh.
- 2 Department of Anatomy and Embryology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. Electronic address: [email protected].
- 3 Department of Hepatology, Mymensingh Medical College and Hospital, Mymensingh, Bangladesh.
- 4 Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
- 5 Department of Anatomy and Embryology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
- 6 Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
No abstract available
MeSH terms
-
Adult
-
Antiviral Agents / therapeutic use*
-
COVID-19 Drug Treatment*
-
COVID-19 Nucleic Acid Testing / methods
-
Female
-
Humans
-
Ivermectin / therapeutic use*
-
Male
-
Prognosis
-
Retrospective Studies
-
Risk Factors
-
SARS-CoV-2*
Substances
-
Antiviral Agents
-
Ivermectin